Despite challenges such as high costs and access barriers, the demand for effective, tailored therapies continues to rise, transforming the psoriasis treatment landscapeDublin, Nov. 26, 2025 (GLOBE ...

The blogger Howard Chang explores the latest advancements bringing hope for a psoriasis cure, some of which were presented at a community event.

FOR Dar es Salaam resident Frank Latamani, the chronic skin condition known as Psoriasis has become not only a painful ordeal ...

An expert panel calls the requirement for tuberculosis testing before prescribing IL-17 and IL-23 biologics for psoriasis an ...

China: Researchers have found in a new study that secukinumab and ixekizumab demonstrate comparable clinical efficacy for ...

Psoriasis can affect the fingers, knuckles, nails, palms, and soles. Here’s what this psoriasis looks like and how to relieve symptoms like itch.

Treatment with envudeucitinib was safe and effective through 52 weeks among patients with with moderate to severe plaque psoriasis.

In older adults with psoriasis or psoriatic arthritis, use of two biologic classes was associated with lowest rates of serious adverse events than time off those drugs.

Patients with psoriasis who receive antibiotics may be more likely to discontinue their biologic therapy, a new study suggests. 1 In this French cohort study, the effect increased with multiple ...

Prescription Drug User Fee Act (PDUFA) target action date set for June 29, 2026If approved, ZORYVE cream 0.3% would be the first and only topical ...

A study published in The New England Journal of Medicine has reported that the oral peptide icotrokinra, a selective ...

Investing.com -- Arcutis Biotherapeutics Inc (NASDAQ:ARQT) stock rose 4.5% on Monday after the FDA accepted the company’s application to expand the use of its psoriasis treatment to younger children.